A Retrospective Cohort Study Outcome of Treatment in Asymptomatic Stage 4 Colorectal Cancer
1 other identifier
observational
135
1 country
1
Brief Summary
In asymptomatic Stage 4 colorectal cancer, the treatment varies between many hospitals and countries. Some studies found that primary tumor resection had better survival rates and a lower risk of mortality. But many studies found significant benefits in survival in sub groups of the population such as age less than 70 years, WHO performance status \<2, no extra-hepatic metastasis, liver tumor burden \<50%. However some studies showed no survival benefits in primary tumor resection. So this study will focus on survival, adverse events, complications in primary tumor resection and no primary tumor resection in asymptomatic Stage 4 colorectal cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2017
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2020
CompletedFirst Submitted
Initial submission to the registry
April 2, 2020
CompletedFirst Posted
Study publicly available on registry
April 6, 2020
CompletedApril 6, 2020
April 1, 2020
3.2 years
April 2, 2020
April 2, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Complication rate
The definition of complication defined as symptom that occurred during treatment period such as obstruction , perforation , bleeding , trenesmus.
5 year
Secondary Outcomes (1)
The survival time
5 year
Interventions
resection of cancer at colon
Eligibility Criteria
Medical records of stage IV colorectal cancer with unresectable distant metastasis received treatment in Ramathibodi hospital between 1 September 2006 - 31 August 2016.
You may qualify if:
- Asymptomatic stage IV colorectal cancer
- pathological prove adenocarcinoma
- age \>18 years
- no primary tumor related symptom
- ECOG performance status \<2
You may not qualify if:
- symptomatic primary tumor such as obstruction , perforation that required surgery
- carcinomatosis peritoneii
- patients with secondary cancer diagnosis in 5 years
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chairat Supsamutchai
Bangkok, Bankok, 10400, Thailand
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Chairat Supsamutchai, MD
270, Rama VI road, Ratchathevi, Deapartment of Surgery, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand, 10400
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 2, 2020
First Posted
April 6, 2020
Study Start
January 1, 2017
Primary Completion
March 1, 2020
Study Completion
March 31, 2020
Last Updated
April 6, 2020
Record last verified: 2020-04